The use of complex herbal supplements for the prevention and treatment of urinary tract infections. The analysis of active components


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Urinary tract infections, especially recurrent cases, are caused by uropathogens, which, after repeated courses of antibiotic therapy, can develop antibiotic resistance, which requires a search for an alternative treatment strategy. In this regard, the restoration of nonspecific protective factors that normally prevent the adhesion and colonization of pathogens is of interest for clinicians. To date, scientific data has been accumulated about the anti-uropathogenic and antiadhesive activity of many plant extracts. However, studies on the specific action of herbal components are limited. Data on the chemical composition, mechanisms of action, in vivo and in vitro efficacy of medicinal plants growing on the European continent and used for the prevention or treatment of acute and chronic (recurrent) urinary tract infections are presented in the review.

Texto integral

Acesso é fechado

Sobre autores

A. Tsukanov

Omsk State Medical University

Email: autt@mail.ru
Ph.D., MD, Professor; Head of the Department of Surgical diseases and Urology with the Course of Additional Professional Education Omsk, Russia

E. Matveev

Omsk State Medical University

Ph.D., assistant at the Department of Surgical diseases and Urology with the Course of Additional Professional Education Omsk, Russia

A. Nurgalieva

Omsk State Medical University

student of Medical Faculty Omsk, Russia

Bibliografia

  1. Wagenlehner F.M., Lichtenstern C., Rolfes C., et al. Diagnosis and management for urosepsis. Int. J. Urol. 2013;20:963-970.
  2. Gur S., Turgut-Balik D., Gur N. Antimicrobial activities and some fatty acids of turmeric, ginger root and linseed used in the treatment of infectious diseases. J. Agricultural Sci. 2006;2:439-442.
  3. Ahmad I., Aqil F. In vitro efficacy of bioactive extracts of 15 medicinal plants against ESβL-producing multidrug-resistant enteric bacteria. Microbiol. Res. 2007;162:264-275.
  4. Sibanda T., Okoh A.I. In vitro evaluation of the interactions between acetone extracts of Garcinia kola seeds and some antibiotics. Afr. J. Biotechnol. 2008;7:1672-1678.
  5. Yarnell E. Botanical medicines for the urinary tract. World J. Urol. 2002;20(5):285-293.
  6. McGuffin M., Kartesz J.T., Leung A.Y., Tucker A.O. American Herbal Product Association’s herbs of сommerce (2nd edn). American Herbal Products Association, Silver Springs, Md., USA. 2000
  7. Lemus I., Garcı´a R., Erazo S., et al. Diuretic activity of an Equisetum bogotense tea (platero herb): Evaluation in healthy volunteers. J. Ethnopharmacol. 1996;54:55-58.
  8. Doan D.D., Nguyen N.H., Doan H.K., et al. Studies on the individual and combined diuretic effects of four Vietnamese traditional herbal remedies (Zea mays, Imperata cylindrica, Plantago major, and Orthosiphon stamineus). J Ethnopharmacol. 1992;36:225-231.
  9. Tyler V. Herbs of choice: the therapeutic use of phytomedicinals. Pharmaceutical Products, Binghampton, N.-Y., 1994.
  10. Schilcher H. Moglichkeiten und Grenzen der Phytotherapie am Beispiel pflanzlicher Urologika. Der Urologe B. 1987;27:316-319.
  11. Galati E.M., Tripodo M.M., Trovato A., et al. Biologic effect of Opuntia ficus indica (L) Mill (Cactaceae) waste matter. Note I: diuretic activity. J. Ethnopharmacol. 2002;79:17-21.
  12. Pantoja C.V., Martı´n N.T., Norris B.C., Contreras C.M. Purification and bioassays of a diuretic and natriuretic fraction from garlic (Allium sativum). J. Ethnopharmacol. 2000;70:35-40.
  13. Yarnell E. Botanical medicines for the urinary tract. World J. Urol. 2002;20:285-293. doi: 10.1007/s00345-002-0293-0.
  14. Kirchhoff H.W. Brennesselsaft als Diuretikum. Z. Phytother. 19834:621-626
  15. Beck J.B., Semple J.C., Brull J.M., et al. Genus-Wide Microsatellite Primers for the Goldenrods (Solidago; Asteraceae). Appl. Plant Sci. 2014;2:1300093.
  16. European Medicines Agency. Assessment Report on Solidago virgaurea L., Herba; European Medicines Agency: London, UK. 2008.
  17. Borchert V.E., Czyborra P., Fetscher C., et al. Extracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2004;369:281-286.
  18. Móricz Á.M., Ott P.G., Häbe T.T., et al. Effect-Directed Discovery of Bioactive Compounds Followed by Highly Targeted Characterization, Isolation and Identification, Exemplarily Shown for Solidago virgaurea. Anal. Chem. 2016;88:8202-8209.
  19. Móricz Á.M., Jamshidi-Aidji M., Krüzselyi D., et al. Distinction and valorization of 30 root extracts of five goldenrod (Solidago) species. J. Chromatogr. A. 2020;1611:460602.
  20. Toiu A., Vlase L., Vodnar D.C., et al. Solidago graminifolia L. Salisb. (Asteraceae) as a Valuable Source of Bioactive Polyphenols: HPLC Profile, In Vitro Antioxidant and Antimicrobial. Potential. Mol. 2019;24:2666.
  21. Dobjanschi L., Paltinean R., Vlase L., et al. Comparative phytochemical research of Solidago genus: S. graminifolia. Note I. Flavonoids. Acta Biol. Marisiensis. 2018;1:18-26.
  22. Choi S.Z., Choi S.U., Lee K.R. Pytochemical constituents of the aerial parts from Solidago virga-aurea var. gigantea. Arch. Pharmacal. Res. 2004;27:164-168.
  23. Dobjanschi L., Fritea L., Patay E.B., et al. Comparative study of the morphological and phytochemical characterization of Romanian Solidago species. Pak. J. Pharm. Sci. 2019;32:1571-1579.
  24. Dobjanschi L., Zdrinca M., Muresan M., et al. The thin layer chromatography analysis of saponins belonging to Solidago species. Fasc. Prot. Mediu. 2013;21:56-60.
  25. Tkachev A.V., Korolyuk E.A., Letchamo W. Volatile Oil-Bearing Flora of Siberia VIII: Essential Oil Composition and Antimicrobial Activity of Wild Solidago virgaurea L. from the Russian Altai. J. Essent. Oil Res. 2006;18:46-50.
  26. Kalemba D., Thiem B. Constituents of the essential oils of four micropropagated Solidago species. Flavour Fragr. J. 2004;19:40-43.
  27. Melzig M., Löser B., Bader G., Papsdor G. European goldenrod as an anti-inflammatory drug: Investigations into the cyto-and molecular pharmacology for a better understanding of the anti-inflammatory activity of preparations from Solidago virgaurea. Z. Phytother. 2000;21:67-70.
  28. Vuolo M.M., Lima V.S., Junior M.R.M. Phenolic compounds: Structure, classification, and antioxidant power. In Bioactive Compounds; Elsevier: Amsterdam, The Netherlands. 2019. Р. 33-50.
  29. Demir H., Acik L., Bali E.B., et al. Antioxidant and antimicrobial activities of Solidago virgaurea extracts. Afr. J. Biotechnol. 2009;8:2.
  30. Fursenco C., Calalb T., Uncu L., et al. Solidago virgaurea L.: a review of its ethnomedicinal uses, phytochemistry, and pharmacological activities Biomolecul. 2020;10:1619. doi: 10.3390/biom10121619.
  31. Meyer B., Schneider W., Elstner E. Antioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea. Arzneimittel-forschung. 1995.
  32. El-Ghazaly M., Khayyal M., Okpanyi S., et al. Study of the antiinflammatory activity of Populus tremula, Solidago virgaurea and Fraxinus excelsior. Arzneimittel-forschung. 1992;42:333-336.
  33. Abdel Motaal A., Ezzat S.M., Tadros M.G., et al. In vivo anti-inflammatory activity of caffeoylquinic acid derivatives from Solidago virgaurea in rats. Pharm. Biol. 2016;54:2864-2870.
  34. Marksa M., Zymone K., Ivanauskas L., et al. Antioxidant profiles of ˙ leaves and inflorescences of native, invasive and hybrid Solidago species. Ind. Crops Prod. 2020;145:112123.
  35. Chodera A., Dabrowska K., Sloderbach A., et al. Effect of flavonoid fractions of Solidago virgaurea L. on diuresis and levels of electrolytes. Acta Pol. Pharm. 1991.
  36. Borchert V.E., Czyborra P., Fetscher C., et al. Extracts from Rhois aromatica and Solidaginis virgaurea inhibit rat and human bladder contraction. Naunyn-Schmiedeberg’s Arch. Pharmacol. 2004:369:281-286.
  37. Edwards S.E., Rocha I., Williamson E.M., et al. Phytopharmacy: An Evidence-Based Guide to Herbal Medical Products; Wiley Blackwell:Chichester, West Sussex, UK; Hoboken, NJ, USA, 2015; ISBN 978-1-118-54345-0.
  38. Chodera A., Dabrowska K., Bobkiewicz-Kozłowska T., et al. Effect ofleiocarposide on experimental urinary calculi in rats. Acta Pol. Pharm.1988;45:181-186.
  39. Liu J., Du C., Beaman H.T., et al. Characterization of Phenolic Acid Antimicrobial and Antioxidant Structure-Property Relationships.Pharmac. 2020;12:419.
  40. Sertel S., Eichhorn T., Plinkert P.K. Efferth T. Chemical Composition and Antiproliferative activity of essential oil from the leaves of a medicinal herb, Levisticum officinale, against UMSCC1 head and neck squamous carcinoma cells, Anticancer Res. 2011;31:185-192.
  41. Miran M., Esfahani H. M., Farimani M.M., et al. Essential oil composition and antibacterial activity of Levisticum officinale Koch at different developmental stages, J. Essent. Oil-Bear. Plants. 2018;21:1051-1055.
  42. Gindikin V.Ya. Herbs, nerves, age. The use of medicinal herbs in neurotic and neurosis-like disorders. M., 2002. 226 p.
  43. Ovchinnikova S.Ya., Orlovskaya T.V. Study of the antispasmodic activity of the extract of rhizomes and roots of the medicinal lovage Scientific bulletin. Medicine series. Pharmacy. 2012;4(123). Issue 17/1 275.
  44. Jakubczyk A., Złotek U., Szymanowska U., et al. In Vitro Antioxidant, Anti-Inflammatory, Anti-Metabolic Syndrome, Antimicrobial, and Anticancer Effect of Phenolic Acids Isolated from Fresh Lovage Leaves [Levisticum officinale Koch] Elicited with Jasmonic Acid and Yeast Extract Antioxidants. 2020;9:554. doi: 10.3390/antiox9060554.
  45. McGuffin M., Hobbs C., Upton R., Goldberg A. (eds). American Herbal Products Association’s botanical safety handbook. CRC, Boca Raton, Fla., USA. 1997.
  46. Naimushina L.V., Krotova I.V., Grodnitskaya I.D., Yakimenko E.E. Investigation of the chemical composition of roots and rhizomes of medicinal lovage. Vestn. KrasGAU. 2010;4:283-87.
  47. Rafsanjany N., Lechtenberg L., Peterei .F, Hensel A. Antiadhesion as a functional concept for protection against uropathogenic Escherichia coli: In vitro studies with traditionally used plants with antiadhesive activity against uropathognic Escherichia coli. J. Ethnopharmacol. 2013;145:591-597.
  48. Ho K.Y., Tsai C.C., Huang J.S., et al. Antimicrobial activity of tannin components from Vaccinium vitis-idaea L. J. Pharm. Pharmacol. 2001;53:187-191.
  49. Kylli P., Nohynek L., Puupponen-Pimia R., et al. Lingonberry (Vaccinium vitis-idaea) and European cranberry (Vaccinium microcarpon) proanthocyanidins: isolation, identification, and bioactivities. J. Agric. Food Chem. 2011;59:3373-3384.
  50. Singh R., Dar S.A., Sharma P. Antibacterial activity and toxicological evaluation of semi purified hexane extract of Urtica dioica leaves. Res J Med Plant. 2012. doi: 10.3923/rjmp.2012.
  51. Wojnicz D., Kucharska A.Z., Sokół-Łętowska A., et al. Medicinal plants extracts affect virulence factors expression and biofilm formation by the uropathogenic Escherichia coli. 2012;40(6):683-697. Doi: 10.1007/ s00240-012-0499-6.
  52. Cusumano C.K., Pinkner J.S., Han Z., et al. Treatment and prevention of urinary tract infection with orally active FimH inhibitors. Sci. Transl. Med. 2011;3:109-115.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2021

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies